Cargando…

Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases

With inconsistent findings, evidence has been obtained in recent years that metabolic disorders are closely associated with the development of lymphomas. Studies and multiple analyses have been published also indicating that some solid tumor survivors develop a secondary lymphoma, whereas some lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Youxi, Shi, Xiaoju, Wang, Xingtong, Zhang, Ping, Bai, Ou, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917635/
https://www.ncbi.nlm.nih.gov/pubmed/35279210
http://dx.doi.org/10.1186/s13578-022-00763-0
_version_ 1784668591047573504
author Yu, Youxi
Shi, Xiaoju
Wang, Xingtong
Zhang, Ping
Bai, Ou
Li, Yan
author_facet Yu, Youxi
Shi, Xiaoju
Wang, Xingtong
Zhang, Ping
Bai, Ou
Li, Yan
author_sort Yu, Youxi
collection PubMed
description With inconsistent findings, evidence has been obtained in recent years that metabolic disorders are closely associated with the development of lymphomas. Studies and multiple analyses have been published also indicating that some solid tumor survivors develop a secondary lymphoma, whereas some lymphoma survivors subsequently develop a second malignant neoplasm (SMN), particularly solid tumors. An interaction between the multiple etiologic factors such as genetic factors and late effects of cancer therapy may play an important role contributing to the carcinogenesis in patients with metabolic diseases or with a primary cancer. In this review, we summarize the current knowledge of the multiple etiologic factors for lymphomagenesis, focusing on the SMN in lymphoma, secondary lymphomas in primary cancers, and the lymphomas associated to metabolic disorders/diseases, which have been received less attention previously. Further, we also review the data of coexistence of lymphomas and hepatocellular carcinoma (HCC) in patients with infection of hepatitis C virus and hepatitis B virus. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8917635
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89176352022-03-21 Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases Yu, Youxi Shi, Xiaoju Wang, Xingtong Zhang, Ping Bai, Ou Li, Yan Cell Biosci Review With inconsistent findings, evidence has been obtained in recent years that metabolic disorders are closely associated with the development of lymphomas. Studies and multiple analyses have been published also indicating that some solid tumor survivors develop a secondary lymphoma, whereas some lymphoma survivors subsequently develop a second malignant neoplasm (SMN), particularly solid tumors. An interaction between the multiple etiologic factors such as genetic factors and late effects of cancer therapy may play an important role contributing to the carcinogenesis in patients with metabolic diseases or with a primary cancer. In this review, we summarize the current knowledge of the multiple etiologic factors for lymphomagenesis, focusing on the SMN in lymphoma, secondary lymphomas in primary cancers, and the lymphomas associated to metabolic disorders/diseases, which have been received less attention previously. Further, we also review the data of coexistence of lymphomas and hepatocellular carcinoma (HCC) in patients with infection of hepatitis C virus and hepatitis B virus. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-03-12 /pmc/articles/PMC8917635/ /pubmed/35279210 http://dx.doi.org/10.1186/s13578-022-00763-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Yu, Youxi
Shi, Xiaoju
Wang, Xingtong
Zhang, Ping
Bai, Ou
Li, Yan
Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
title Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
title_full Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
title_fullStr Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
title_full_unstemmed Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
title_short Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
title_sort second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917635/
https://www.ncbi.nlm.nih.gov/pubmed/35279210
http://dx.doi.org/10.1186/s13578-022-00763-0
work_keys_str_mv AT yuyouxi secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases
AT shixiaoju secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases
AT wangxingtong secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases
AT zhangping secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases
AT baiou secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases
AT liyan secondmalignantneoplasmsinlymphomassecondarylymphomasandlymphomasinmetabolicdisordersdiseases